0001104659-25-004548.txt : 20250117 0001104659-25-004548.hdr.sgml : 20250117 20250117170317 ACCESSION NUMBER: 0001104659-25-004548 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250117 DATE AS OF CHANGE: 20250117 EFFECTIVENESS DATE: 20250117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DarioHealth Corp. CENTRAL INDEX KEY: 0001533998 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 452973162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-535696 FILM NUMBER: 25539468 BUSINESS ADDRESS: STREET 1: 322 W 57TH ST. #33B CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 972-4-770-6377 MAIL ADDRESS: STREET 1: 322 W 57TH ST. #33B CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: LabStyle Innovations Corp. DATE OF NAME CHANGE: 20111101 D 1 primary_doc.xml X0708 D LIVE 0001533998 DarioHealth Corp. 322 W 57TH ST. #33B NEW YORK NY NEW YORK 10019 972-4-770-6377 DELAWARE None LabStyle Innovations Corp. Corporation true Zvi Ben David 322 W 57th St. #33B New York NY NEW YORK 10019 Executive Officer Chief Financial Officer, Treasurer, and Secretary Erez Raphael 322 W 57th St. #33B New York NY NEW YORK 10019 Executive Officer Director Chief Executive Officer Steven Nelson 322 W 57th St. #33B New York NY NEW YORK 10019 Executive Officer Chief Commercial Officer Yoav Shaked 322 W 57th St. #33B New York NY NEW YORK 10019 Director Chairman of the Board Dennis Matheis 322 W 57th St. #33B New York NY NEW YORK 10019 Director Hila Karah 322 W 57th St. #33B New York NY NEW YORK 10019 Director Dennis M. McGrath 322 W 57th St. #33B New York NY NEW YORK 10019 Director Jon Kaplan 322 W 57th St. #33B New York NY NEW YORK 10019 Director Adam K. Stern 322 W 57th St. #33B New York NY NEW YORK 10019 Director Other Technology Decline to Disclose 06b false 2025-01-07 false true true false 1000 6800000 6800000 0 Represents a purchase price for 4,950 shares of Series D-2 Preferred Stock and 1,850 shares of Series D-3 Preferred Stock (together, "Preferred Stock"). The Preferred Stock is convertible into shares of the issuer's common stock, par value $0.0001. false 18 0 0 0 false DarioHealth Corp. /s/ Zvi Ben David Zvi Ben David Chief Financial Officer, Treasurer, and Secretary 2025-01-17